chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A physician reported the occurrence of limb swelling in a child of unspecified age and gender who was vaccinated with Infanrix for prophylaxis. The vaccine provider submitted a report directly to VAERS. The subject's medical history, concurrent conditions, and concurrent medications were not reported. On an unspecified date, the subject received an injection of Infanrix. At an unspecified time post-immunization, the subject developed "pretty serious" limb swelling. The subject was treated at a "minor emergency" center "and received treatment with an anti-inflammatory" drug. The reporter indicated that the event was probably related to Infanrix administration. As of 9/12/02, the outcome of the event was unknown. This report has been linked to report A0385107A due to same reporter.
Chills and shivering; This case was reported by a consumer and described the occurrence of shivering in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent 2020-2021 season) for prophylaxis and PNEUMOCOCCAL VACCINE (PNEUMONIA VACCINE) for prophylaxis.   In September 2020, the patient received the 1st dose of Shingrix, Influenza vaccine Quadrivalent 2020-2021 season and PNEUMONIA VACCINE. On an unknown date, less than 9 months after receiving Shingrix and Influenza vaccine Quadrivalent 2020-2021 season, the patient experienced shivering. On an unknown date, the outcome of the shivering was unknown.   It was unknown if the reporter considered the shivering to be related to Shingrix and Influenza vaccine Quadrivalent 2020-2021 season.  Additional details were provided as follows: The case was reported by patient for herself. The age at vaccination was not reported. The patient received 1st Shingrix and on the same day received the flu shot and pneumonia shot, and less than 9 months after vaccination, the patient experienced chills with shivering.  Reporter declined to provide demographic information and declined to answer any adverse event related questions. It was unknown if the reporter considered the shivering to be related to pneumonia vaccine. No other information was provided. The reporter declined to provide health care professional information. The reporter did not consent to follow up.
Patient had vaccine in March 2021, had acute  CVA in September 2021.   It is my medical opinion that this is not related to the Janssen COVID-19 vaccine because the stroke is remote from the vaccine administration, and in a patent with previous history of strokes, hypertension, and diabetes.
Couldn't breath/Couldn't catch breath; Whole body burning; Throat was burning; Couldn't see out of the right eye; Cant talk for long/Talking is the worst/It hurts to talk; Feels like and elephant is in the chest; Chest pain; Can't do anything; Allergic reaction; After the booster they report felling dizzy; Huge lump under left arm; Headaches; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Couldn't breath/Couldn't catch breath), BURNING SENSATION (Whole body burning), THROAT IRRITATION (Throat was burning), OCULAR DISCOMFORT (Couldn't see out of the right eye) and SPEECH DISORDER (Cant talk for long/Talking is the worst/It hurts to talk) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history was provided by the reporter. Concomitant products included VITAMINS NOS for an unknown indication.On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form.On 28-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In December 2021, the patient experienced DYSPNOEA (Couldn't breath/Couldn't catch breath), BURNING SENSATION (Whole body burning), THROAT IRRITATION (Throat was burning), OCULAR DISCOMFORT (Couldn't see out of the right eye), SPEECH DISORDER (Cant talk for long/Talking is the worst/It hurts to talk), CHEST DISCOMFORT (Feels like and elephant is in the chest), CHEST PAIN (Chest pain), IMPAIRED WORK ABILITY (Can't do anything), HYPERSENSITIVITY (Allergic reaction), DIZZINESS (After the booster they report felling dizzy), VACCINATION SITE MASS (Huge lump under left arm) and HEADACHE (Headaches). At the time of the report, DYSPNOEA (Couldn't breath/Couldn't catch breath), BURNING SENSATION (Whole body burning), THROAT IRRITATION (Throat was burning), OCULAR DISCOMFORT (Couldn't see out of the right eye), SPEECH DISORDER (Cant talk for long/Talking is the worst/It hurts to talk), CHEST DISCOMFORT (Feels like and elephant is in the chest), CHEST PAIN (Chest pain), IMPAIRED WORK ABILITY (Can't do anything), HYPERSENSITIVITY (Allergic reaction), DIZZINESS (After the booster they report felling dizzy), VACCINATION SITE MASS (Huge lump under left arm) and HEADACHE (Headaches) outcome was unknown. It was stated that Patient was questioned for Myocarditis and Pericarditis for which Patient answered negative to everything.Patient also stated that she don't smoke, drink or do drugs, and that they have to stop working because of this.No treatment details were reported.  This case was linked to MOD-2021-435933, MOD-2021-435962 (Patient Link).
4" x 2" reddened hot area (L) deltoid x 1 day.
Client stated that he was waiting in observation and told his father he felt dizzy at which time he closed his eyes and passed out per his father for approximately ten seconds. Onsite paramedics responded and evaluated client. Client released to go AMA and advised to go emergency services.
swollen injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE SWELLING (swollen injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE SWELLING (swollen injection site). At the time of the report, INJECTION SITE SWELLING (swollen injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant information  provided. Treatment included Icing
Pressure in upper chest left and right side, sometimes moves toward back left.  Sensations in heart, tightness.  Coughing related to fluid in chest.  While sleeping on side, can feel heart beating inside against chest.  Elevated heart rate resting.  Dizziness upon standing.  Appears to be a correlation with headache pressure: forehead, brain stem region.   Professional cyclist in excellent health,  overall  fitness.
This spontaneous case was reported by a consumer and describes the occurrence of PAIN in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.  Medical history was not provided by reporter. Concomitant products included SYNTHROID, AMLODIPINE, METOPROLOL, ISOSORBIDE, ATORVASTATIN, VITAMINS, and ASPIRIN for an unknown indication. On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced PAIN. At the time of the report, PAIN outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were provided.   This case was linked to MOD-2021-074967.
Patients left arm was red with central paleness on deltoid area.  Patient came in with 100.9F fever which has lasted four days with fussiness and irritability.
ON 02/02/2011, FEVER, ON 2/03/2011, BREATHING DIFFICULTY
Fire department dispatched to a medical allergic reaction at the Vaccination Clinic. 31 year old female was awake and talking with no distress. She was alert of the place, time, and events. 20 minutes after receiving her first dose of the COVID-19 Moderna vaccine, she was experiencing numbness in the tongue and hives in the upper chest. Vital signs obtained on scene. Patient denied any chest pain, DIB, trauma, and illness. She was put onto a stretcher and moved to ambulance. Patient said she was experiencing numbness in the side of her face while in the ambulance, so an IV was put into her. She was transported to the ER.
I started to lose my sight, at first it was my entire peripheral vision and it looked like I was looking through a black holed telescope and then I completely lost sight; Crashed into a stand and passed out; I got really dizzy; I sat in a chair where I became incredibly hot; Sweat through all my clothes; Immediately extremely cold; crashed into a stand; This is a spontaneous report from a contactable consumer (the patient). A 21-year-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EW0173) via an unspecified route of administration in left arm on 13May2021 18:00 at age of 21-year-old at single dose for COVID-19 immunisation. Prior to vaccination, the patient diagnosed with COVID-19. No known allergies. No other medical history. Concomitant medication included: the patient received birth control medication within 2 weeks of vaccination. The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EP7533) via an unspecified route of administration on 19Apr2021 01:15 PM at age of 21-year-old for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient had not been tested for COVID-19 since the vaccination. The patient got really dizzy, then as she tried to walk away she started to lose her sight, at first it was her entire peripheral vision and it looked like she was looking through a black holed telescope and then she completely lost sight. She became very dizzy and crashed into a stand and passed out. While she was passed out on the floor she uncontrollably defected. Once someone helped her up, she sat in a chair where she became incredibly hot, sweat through all her clothes and then immediately extremely cold. The events onset date reported as 14May2021 09:00AM. No treatment received for the events. The outcome of the events was recovering. The report was non-serious.
expired vials were used to provide 38 doses; Sore arm; some identified common side effects after the vaccine (ex: sore arm, etc.); This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (Sore arm), VACCINATION COMPLICATION (some identified common side effects after the vaccine (ex: sore arm, etc.)) and EXPIRED PRODUCT ADMINISTERED (expired vials were used to provide 38 doses) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired vials were used to provide 38 doses). In November 2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and VACCINATION COMPLICATION (some identified common side effects after the vaccine (ex: sore arm, etc.)). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (expired vials were used to provide 38 doses) had resolved. In November 2021, PAIN IN EXTREMITY (Sore arm) and VACCINATION COMPLICATION (some identified common side effects after the vaccine (ex: sore arm, etc.)) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  No vial went any temperature excursions.  On 12-Nov-2021, all vaccines were administered within 2 hours.  Some of patient received booster dose on 1-Nov-2021, 05-Nov-2021, 11-Nov-2021 and 12-Nov-2021. Till 19-Nov-2021, there were no adverse reactions to the vaccine.  As of 19 Nov 2021, there were no adverse reactions to the vaccine reported by the list below. We spoke with some that received the vaccine during these dates and some identified common side effects after the vaccine (ex: sore arm, etc.) and only lasted for a few hours but no more than 24 hours for 1st dose, 2nd dose and Booster.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 18-Nov-2021: The additional information included suspect administration date. On 19-Nov-2021: Non-Significant Follow Up Appended : Second reporter Information was updated On 19-Nov-2021: Significant FU appended (Second reporter Information was updated)
shingles; Information has been received from a lawyer regarding a case in litigation and refers to a patient (pt) of unknown age and gender. No information was provided regarding medical history, concurrent conditions, or concomitant medications. In 2016, the pt was inoculated with zoster vaccine live (ZOSTAVAX) (strength, dose, dose number, route, anatomical site of vaccination, lot number and expiration date were not provided) as prescribed and/or administered by a pharmacist for the long-term prevention of shingles and/or zoster-related conditions. On an unknown date (reported as subsequent to pt's zoster vaccine live (ZOSTAVAX) inoculation), the pt was treated by a healthcare provider at a medical office for shingles (herpes zoster). On an unknown date, the pt was admitted to the hospital due to the event. As a direct and proximate result of pt's use of the zoster vaccine live (ZOSTAVAX) vaccine, the pt had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and would continue to suffer such losses, and damages in the future. At the time of this report, the outcome of herpes zoster was unknown. The lawyer considered the event to be related to zoster vaccine live (ZOSTAVAX).
MODERATE PAIN (6/10) AT INJECTION SITE began within 30 minutes of vaccine administration. Ibuprofen provided no pain relief, taken once 4 hours post-vaccine administration, and again 8 hours after. 24 hours after initial injection given, at work (I am a medical student rotating in neurology at the clinical site where the vaccine was administered), I felt severe pain at injection site (10/10), radiating toward my left shoulder blade. The pain was so severe, I could not continue my work. I applied an ice pack to my arm and took Ibuprofen, sat on the floor in the dark to wait for relief. I felt my heart racing, hyperventilating (likely due to pain), became diaphoretic, and experienced photophobia as well as tremulous shaking. After approximately 30 minutes, a supervisor found me and alerted emergency med techs on staff, who measured vitals and rushed me to the Emergency Department of our hospital. The pain began to subside to 5/10 after an hour in the ED, where I was treated with intravenous fluid (NS), diphenhydramine PO, and metoclopramide PO. I was stabilized, pain under control (3/10), and released approximately 3 hours after admission, at 3:15 PM.
I was unusually fatigued for the rest of the day after getting the vaccine on 04/01/2016. The following day, 04/02/2016, I had muscle aches from the time I got up in the morning. Aches got worse until I took two ibuprofen around 12 PM.  Now it is about 4 PM and the only ache remaining is in my upper back/shoulders.
Booster dose for healthy adult? We gave 0.5 mL; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of ACCIDENTAL OVERDOSE (Booster dose for healthy adult? We gave 0.5 mL) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On an unknown date, the patient experienced ACCIDENTAL OVERDOSE (Booster dose for healthy adult? We gave 0.5 mL). At the time of the report, ACCIDENTAL OVERDOSE (Booster dose for healthy adult? We gave 0.5 mL) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.   No treatment information provided.
This is in follow-up to report(s) previously submitted on 4/13/2007. Information has been received from a nurse concerning her daughter (age not reported) who on an unspecified date was vaccinated IM with a 0.5 mL first dose of Gardasil. Subsequently the patient experienced eczema on both arms. The patient sought unspecified medical attention. The patient's physician believed that the eczema may have been due to the high aluminum content in the vaccine. No additional information is expected.
Chills, achiness, difficulty breathing, fatigue, headache, other flu-like symptoms
Presented with red lesion or nodular at the right anterior thigh after her vaccines at 12 months. Her vaccines were given about one week ago. It is in the location of the varicella vaccine. The area was red the following day and it slowly getting bigger. The redness is bigger and it seems warm. No streaks. No discharge. She had fever start last night to about 100 F. Treated with KEFLEX 125 mg/5 mL suspension 5/25/2018- 6/4/2018 Take 4 mL (100 mg) by mouth 3 times daily for 10 days. She is acting more tired and more fussy. Mother has given her acetaminophen.
inconsolable crying x 15min when reported, taken to PMD, no tx lt thigh to knee reddened;
Serious pain from injection site shooting up through shoulder and up neck toward ear. Strong pain - I get the flu shot each year and have never had this before. Some nausea and weakness. Had to lie down for a while to get control over pain. Still hurts on neck area bad.
Tested positive for COVID on 07/27/2021 does not have any symptoms but was exposed to COVID.  Is in a Rehab center and 3 of the employee had tested positive.
First day night with inflammation in my deep nose and feeling chills. Second day the mucus start to come out and had sore throat. At night, I had the fever and the headache that I couldn't even sleep.  I took the coughing syrup and barely slept.
13x10cm area of erythema and induration distal to injection site. Began or 24 hrs after vaccination. Pt seen in office at 48 hrs.
Shoulder became frozen; Real severe pain; Couldn't move for 2 days; Pain has been extended over the neck (L side); Pain has been extended over the leg (L side); Pain has been extended over to the hips (L side); This spontaneous case was reported by a consumer and describes the occurrence of PERIARTHRITIS (Shoulder became frozen), PAIN (Real severe pain), MOBILITY DECREASED (Couldn't move for 2 days), NECK PAIN (Pain has been extended over the neck (L side)) and PAIN IN EXTREMITY (Pain has been extended over the leg (L side)) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010"N" 120A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy, Food allergy (Sensitive to food additives) and Chronic fatigue. Concomitant products included GABAPENTIN for Neuropathy and Hot flashes, AMITRIPTYLINE for Sleep deficit.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced PERIARTHRITIS (Shoulder became frozen), PAIN (Real severe pain), MOBILITY DECREASED (Couldn't move for 2 days), NECK PAIN (Pain has been extended over the neck (L side)), PAIN IN EXTREMITY (Pain has been extended over the leg (L side)) and ARTHRALGIA (Pain has been extended over to the hips (L side)). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. On 27-Feb-2021, PERIARTHRITIS (Shoulder became frozen), PAIN (Real severe pain), MOBILITY DECREASED (Couldn't move for 2 days), NECK PAIN (Pain has been extended over the neck (L side)), PAIN IN EXTREMITY (Pain has been extended over the leg (L side)) and ARTHRALGIA (Pain has been extended over to the hips (L side)) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Mar-2021, Body temperature: 103 f 103 F.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 09-Jul-2021: VAER's report received. patient details ,concomitant medication, medical history updated.
Patient  reports that she feels like her heart is racing, flushed face, and numbness and tingling to extremities and feels anxious. Patient denies CP, SOB, throat fullness, difficulty swallowing. Patient reported that she had a similar reaction after having cortizone injection a couple of weeks ago.  Patients vitals were continously monitored , an EKG was ordered as heart rate was 122 on examination. before discharge her  vitals were BP 130/80, HB 84/ oxygen levels 99%.  Our Medical Director saw patient before discharge and recommended tha she go to ER for safety. Patient declined. Patient was called at 4:47 pm to check her status. Patient said feeling better.
Patient was inadvertently given the influenza vaccine adult formulation to be used for age 18 yrs and over.  Parent of child notified on same day after we contacted the vaccine manufacturer.  We informed parent of possible side affects to watch for, such as increase pain, redness, swelling, fever,headache, cough, sore throat.  Parent instructed to call back immediately to the office if they observe any of the symptoms.
Received Flumist, was unaware that she was 2 weeks pregnant at the time of administration.
Aches, chills, headache, temperature of, eventually, 102.5° Event lasted until the afternoon of 12/11/2021
Upper lip and surrounding face began to tingle and swell. Heart fluttered/felt like it was skipping beats. I also had pain in my right arm that radiated into my neck and down to my fingers. I felt shivery and my cheeks were flushed.
Extreme diarhea, gas, and lower back pain beginning about 10:30 PM the day after receiving  the vaccine injection. The pain is centered in the area of the surgeries (L3- L5) There was no discomfort at the injection site after the injection. There was no significant physical activity or strain, and no extraordinary dietary changes prior to the reactions. the injection may not be the cause of pain and diarhea, but some of the possible reactions include "..muscle pain.. and feeling unwell". My primary concerns are: 1) Will the back pain subside?  It is less now, and I hope it will return to normal in time.  2) Should I take any additional injections of the vaccine?
Patient has a sparse widespread itchy rash and  fever of 100 axillary. Patient was given Tylenol and Benadryl by his parents.